Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Esperion Theraptc (NQ: ESPR )

6.450 +0.090 (+1.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 610,564
Open 6.300
Bid (Size) 6.280 (2)
Ask (Size) 6.900 (1)
Prev. Close 6.360
Today's Range 6.120 - 6.470
52wk Range 3.280 - 20.75
Shares Outstanding 28,277,493
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 12.6% to $0.58 during Friday's after-market session. The market value of their outstanding shares is at $8.9 million. 
Via Benzinga

Performance

YTD
+24.28%
+24.28%
1 Month
+10.63%
+10.63%
3 Month
+22.86%
+22.86%
6 Month
+24.28%
+24.28%
1 Year
-67.52%
-67.52%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2022
Via Benzinga
Esperion Therapeutics: Q1 Earnings Insights
Via Benzinga
Earnings Scheduled For February 22, 2022
Via Benzinga
A Peek Into The Markets: US Stock Futures Down Following Wednesday's Surge
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
Via Benzinga
Esperion Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2022
Via Benzinga
73 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Recap: Esperion Therapeutics Q4 Earnings
Via Benzinga
10 Biggest Price Target Changes For Thursday
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Charms Of China
Via Talk Markets
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
58 Biggest Movers From Friday
Via Benzinga
Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.